Taken together, these data suggest that Plk2 is an anti-oxidative and anti-inflammatory regulator by phosphorylating Nrf2, which then triggers translocalization of Nrf2 into the nuclei and expression of anti-oxidative and anti-inflammatory gene products for the protection of the cells from AKI (Fig. 7g). Here, NFE2L2 is linked to acute kidney injury.